Targeting glutaminolysis via inhibition or genetic ablation of the enzyme glutaminase 1 (GLS1) inhibits RA FLS proliferation and ameliorates the severity of experimental autoimmune arthritis [80]. Here, GLS is linked to rheumatoid arthritis.